Life Sciences Operations

Over the past year, enterprises have had to overcome a series of macroeconomic and geopolitical challenges. The potential uncertainties with the implementation of the Inflation Regulation Act (IRA) and the rise in federal interest rates to curb inflation, compounded by an ongoing war resulting in the shifting of clinical trials from Russia and Ukraine, have forced enterprises to rethink their strategies. Further, the advent of generative, AI such as ChatGPT, will enable the biopharma and MedTech firms to repackage their offerings and provide cutting-edge technology and cost optimization.

To effectively serve evolving enterprise needs, service providers have invested in increasing the breadth and depth of their functionalities/offerings across the life sciences operations value chain. They have invested in a host of avenues, such as Decentralized Clinical Trials (DCT), with many Information Technology / Business Process Outsourcing (IT/BPOs) companies partnering with DCT providers. Further investments include analytics-driven tools for razor-sharp Healthcare Professional (HCP) profiling and targeting and the use of automation tools in areas such as Adverse Events (AE) intakes to rapidly evolve with the market needs.

Life Sciences Operations

What is in this PEAK Matrix® Report

In this research, we present a detailed assessment of 28 operations service providers featured on the Life Sciences Operations Services PEAK Matrix®. We provide a relative positioning and analysis of the providers’ market shares, along with our evaluation of their strengths and limitations. This report will enable enterprises to identify suitable service providers to manage the evolving needs of their businesses.
 
 

In this report, we provide:

  • The relative positioning of the providers on Everest Group’s PEAK Matrix® for Life Sciences Operations Services
  • A comparison of the providers’ capabilities and market shares
  • Everest Group’s analysis of the providers’ strengths and limitations

Scope:

  • Industry: life sciences BPS
  • Geography: global
  • The assessment is based on Everest Group’s annual RFI process for calendar year 2023, interactions with leading life sciences operations service providers, client reference checks, and an ongoing analysis of the life sciences operations market.

Related PEAK Matrix® Assessments

Insurance Intermediaries Services
PEAK Matrix®

Insurance Intermediaries Services PEAK Matrix® Assessment 2024

Marketing Services PEAK Matrix® Assessment 2024
PEAK Matrix®

Marketing Services PEAK Matrix® Assessment 2024

Financial Crime and Compliance (FCC) Operations Services
PEAK Matrix®

Financial Crime and Compliance (FCC) Operations Services PEAK Matrix® Assessment 2024

Life Sciences Digital Services Specialists PEAK Matrix® Assessment 2024
PEAK Matrix®

Life Sciences Digital Services Specialists PEAK Matrix® Assessment 2024

Our Latest Thinking

06 25 2024 Winning Commercial JoinUs 1200x628
Events

Winning Commercial and Solution Sizing Approaches in Technology Sourcing Deals

05-30-2024_Strategic Sustainability Partnerships_Join us_1200x628
Events

Strategic Sustainability Partnerships: Aligning Objectives for Long-term Impact

GettyImages 914474860
Blog

The Future of the Wealth Management Industry: The S-curve Shift and the Modernization Opportunity

GettyImages 629112052
Blog

Are Investors Right to Be Nervous about CXM Providers? Well, It Depends!

What is the PEAK Matrix®?

The PEAK Matrix® provides an objective, data-driven assessment of service and technology providers based on their overall capability and market impact across different global services markets, classifying them into three categories: Leaders, Major Contenders, and Aspirants.

LEARN MORE ABOUT Top Service Providers

How can we engage?

Please let us know how we can help you on your journey.

Contact Us

"*" indicates required fields

Please review our Privacy Notice and check the box below to consent to the use of Personal Data that you provide.